Leprosy: The human infection with Mycobacterium leprae

被引：0

作者：

Schöffel N. ^{[1
]}

Braun M. ^{[1
]}

Volante G. ^{[1
]}

Bendels M.H.K. ^{[1
]}

Groneberg D.A. ^{[1
]}

机构：

[1] Institut für Arbeitsmedizin, Sozialmedizin und Umweltmedizin, Goethe-Universität Frankfurt, Theodor-Stern-Kai 7, Frankfurt am Main

来源：

Zentralblatt für Arbeitsmedizin, Arbeitsschutz und Ergonomie | 2018年 / 68卷 / 5期

关键词：

Hansen’s disease; Infectious disease; Leprosy; Mycobacterium leprae; Mycobacterium lepromatosis;

D O I：

10.1007/s40664-017-0245-6

中图分类号：

学科分类号：

摘要：

Leprosy can develop as a result of a chronic infection with Mycobacterium leprae. The majority of cases of leprosy occur in rural regions of Southeast Asia, in tropical regions of Africa and in South America. Leprosy is uncommon in developed countries. Most of the cases are imported from endemic regions. The main reservoir for the transmission of the pathogen are humans. So far two transmission routes into the human body have been described: via skin lesions and the airways. Despite effective treatment and educational measures, leprosy continues to be a problem of stigmatization. Contrary to popular belief, leprosy is not highly contagious. There are two different types of leprosy known: paucibacillary and multibacillary. However, to date it has not been possible to culture the pathogen in vitro. There are various aspects of major occupational importance particularly for travellers visiting endemic regions. This article gives a brief review of the current state of knowledge about epidemiology, pathology, diagnostics, treatment and prevention. © 2017, Springer Medizin Verlag GmbH.

引用

页码：270 / 273

页数：3

共 27 条

[1]

Diel R., Loddenkemper R., Nienhaus A., Consequences of tuberculosis among asylum seekers for health care workers in Germany, J Occup Med Toxicol, 11, (2016)

[2]

Du Mortier S., Mukangu S., Sagna C., Et al., A decade of an HIV workplace programme in armed conflict zones

[3]

a social responsibility response of the International Committee of the Red Cross, J Occup Med Toxicol, 11, (2016)

[4]

Duthie M.S., Gillis T.P., Reed S.G., Advances and hurdles on the way toward a leprosy vaccine, Hum Vaccin, 7, pp. 1172-1183, (2011)

[5]

Groneberg D.A., Jager M., Muller R., Arbeits-, reise- und tropenmedizinisch relevante Infektionserkrankungen, Zentralbl Arbeitsmed Arbeitsschutz Ergonomie, 67, pp. 62-63, (2017)

[6]

Handl V.K., Klingelhofer D., Schoffel N., Et al., Kongenitale Toxoplasmose und Toxoplasma gondii, Zentralbl Arbeitsmed Arbeitsschutz Ergonomie, 66, pp. 239-248, (2016)

[7]

Irgens L.M., The discovery of the leprosy bacillus, Tidsskr Nor Laegeforen, 122, pp. 708-709, (2002)

[8]

Ishida Y., Pecorini L., Guglielmelli E., Three cases of pure neuritic (PN) leprosy at detection in which skin lesions became visible during their course, Nihon Hansenbyo Gakkai Zasshi, 69, pp. 101-106, (2000)

[9]

Lamberti M., De Rosa A., Garzillo E.M., Et al., Vaccination against hepatitis b virus: are Italian medical students sufficiently protected after the public vaccination programme?, J Occup Med Toxicol, 10, (2015)

[10]

Meredith A., Del Pozo J., Smith S., Et al., Leprosy in red squirrels in Scotland, Vet Rec, 175, pp. 285-286, (2014)

← 1 2 3 →